These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8674162)

  • 1. Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors.
    Kreis W; Budman DR; Vinciguerra V; Hock K; Baer J; Ingram R; Schacter LP; Fields SZ
    Cancer Chemother Pharmacol; 1996; 38(4):378-84. PubMed ID: 8674162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of high-dose etoposide phosphate in man.
    Fields SZ; Budman DR; Young RR; Kreis W; Ingram R; Schulman P; Cherny RC; Wright J; Behr J; Snow C; Schacter LP
    Bone Marrow Transplant; 1996 Nov; 18(5):851-6. PubMed ID: 8932836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days.
    Thompson DS; Greco A; Miller AA; Srinivas NR; Igwenezue KB; Hainsworth JD; Schacter LP; Kaul S; Barbhaiya RH; Garrow C
    Clin Pharmacol Ther; 1995 May; 57(5):499-507. PubMed ID: 7768072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
    Fields SZ; Igwemezie LN; Kaul S; Schacter LP; Schilder RJ; Litam PP; Himpler BS; McAleer C; Wright J; Barbhaiya RH
    Clin Cancer Res; 1995 Jan; 1(1):105-11. PubMed ID: 9815892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors.
    Budman DR; Igwemezie LN; Kaul S; Behr J; Lichtman S; Schulman P; Vinciguerra V; Allen SL; Kolitz J; Hock K
    J Clin Oncol; 1994 Sep; 12(9):1902-9. PubMed ID: 8083713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients.
    Kaul S; Srinivas NR; Mummaneni V; Igwemezie LN; Barbhaiya RH
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):23-9. PubMed ID: 8996572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors.
    Kaul S; Igwemezie LN; Stewart DJ; Fields SZ; Kosty M; Levithan N; Bukowski R; Gandara D; Goss G; O'Dwyer P
    J Clin Oncol; 1995 Nov; 13(11):2835-41. PubMed ID: 7595746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical and pharmacokinetic study of oral etoposide phosphate.
    Sessa C; Zucchetti M; Cerny T; Pagani O; Cavalli F; De Fusco M; De Jong J; Gentili D; McDaniel C; Prins C
    J Clin Oncol; 1995 Jan; 13(1):200-9. PubMed ID: 7799021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481).
    Millward MJ; Newell DR; Mummaneni V; Igwemezie LN; Balmanno K; Charlton CJ; Gumbrell L; Lind MJ; Chapman F; Proctor M
    Eur J Cancer; 1995 Dec; 31A(13-14):2409-11. PubMed ID: 8652278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacokinetic study of etoposide phosphate.
    Brooks DJ; Srinivas NR; Alberts DS; Thomas T; Igwemzie LM; McKinney LM; Randolph J; Schacter L; Kaul S; Barbhaiya RH
    Anticancer Drugs; 1995 Oct; 6(5):637-44. PubMed ID: 8845473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patients.
    Kaul S; Srinivas NR; Igwemezie LN; Barbhaiya RH
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):15-22. PubMed ID: 8996571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer.
    Soni N; Meropol NJ; Pendyala L; Noel D; Schacter LP; Gunton KE; Creaven PJ
    J Clin Oncol; 1997 Feb; 15(2):766-72. PubMed ID: 9053503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAC fixed dose: pharmacokinetics of a 1-hour paclitaxel infusion and comparison to BSA-normalized drug dosing.
    Mross K; Holländer N; Frost A; Unger C; Ziroli V; Massing U
    Onkologie; 2006 Oct; 29(10):444-50. PubMed ID: 17028453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of toxicokinetics and toxicodynamics following intravenous administration of etoposide phosphate in beagle dogs.
    Igwemezie LN; Kaul S; Barbhaiya RH
    Pharm Res; 1995 Jan; 12(1):117-23. PubMed ID: 7724471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
    Reif S; Kingreen D; Kloft C; Grimm J; Siegert W; Schunack W; Jaehde U
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):134-40. PubMed ID: 11561779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation.
    Dorr RT; Briggs A; Kintzel P; Meyers R; Chow HH; List A
    Bone Marrow Transplant; 2003 Apr; 31(8):643-9. PubMed ID: 12692603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early studies of etoposide phosphate, a water-soluble prodrug.
    Budman DR
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):8-14. PubMed ID: 8996570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of etoposide short-term infusions within the scope of the GPOH therapy protocol].
    Boos J; Real E; Schulze-Westhoff P; Pröbsting B; Wolff J; Jürgens H
    Klin Padiatr; 1993; 205(4):288-94. PubMed ID: 8377449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.